Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) Receives U.S. FDA Approval for an Additional Indication in Children and Adolescents Aged 2–17 Years at Increased Risk for Pneumococcal Disease

reaction (e.g., anaphylaxis) to any component of CAPVAXIVE or to diphtheria toxoid; see additional Select Safety Information below. The indication for the prevention of pneumonia caused by S. pneumoniae serotypes 3, 6A, 7F, 8, 9N, 10A, 11A, 12F,...

Avenacy Announces the U.S. Launch of Bortezomib for Injection

facilitate safe and efficient patient care, Avenacy strives to be a trusted partner for essential medications. For more information please visit, www.avenacy.com

WISE Closes Oversubscribed €30 Million Series D Financing Round with ENEA Tech and Biomedical Joining as Strategic Investor

while also driving the commercial scale-up of WISE's full electrode portfolio across target markets. A Differentiated Platform for Next-Generation Neurotechnology WISE's proprietary Supersonic Technology enables the production of implantable...

Rugiet Launched Physician-Prescribed Peptide and Longevity Therapies, Setting a New Standard in Performance Medicine

Rugiet, the performance medicine company that’s helped more than 500,000 men take control of their health, announced the expansion of its treatment areas to include longevity. Rugiet is bringing its physician-prescribed standards to an emerging...

Bayer’s AMBELVIST® (gadoquatrane) Gains FDA Approval for Contrast-Enhanced MRI in Detection of Lesions with Abnormal Vascularity Across CNS and Non-CNS Body Regions

human body. This type of study can play an important role in detecting abnormalities, monitoring disease progression and informing treatment decisions.3 For some adults and children with chronic diseases or conditions that require close, long-term...

EVERY and Huvepharma Announce Fourfold Expansion of Production Capacity

is a direct response to the market’s clear signal: the food industry is ready for egg proteins that deliver parity on performance without the supply chain challenges endemic in the global egg supply chain." The expanded production will primarily...

Results from Incyte’s Phase 3 frontMIND Trial of Tafasitamab Combination Show Prolonged Progression-Free Survival Presented at EHA 2026

of next-generation medicines across our key franchises: Hematology, Oncology and Inflammation & Autoimmunity. For more information please visit, www.Incyte.com

DIA Global Annual Meeting

Day: Celebrate breakthroughs and emerging players shaping the next generation of therapies. And More to Come: Fresh formats, dynamic networking experiences, and unique ways to connect across disciplines. Be part of the next chapter in life...

AbbVie Presents EHA 2026 Data on VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Nine-Year Outcomes

— and therefore time off treatment — after one year of fixed-duration therapy. This research advances our mission to transform care and deliver better outcomes for patients living with difficult-to-cure blood cancers." "Venetoclax in combination...

Leading Dermatologist Dr. Dendy Engelman Joins ELASTEN® to Advance the Future of Science-Backed Skin Health from Within

is a shared belief that consumers deserve greater transparency and education around skin health, empowering them to make informed decisions based on clinical evidence rather than marketing claims. "As interest in ingestible skincare continues to...

Breast Milk–Inspired Synbiotic for Infant Gut Health Developed Through Partnership Between NurtureBio and Lallemand

in microbiome science and inspired by the biology of human milk." "Partnering with NurtureBio is a privilege to have a platform where our extensive know-how in microbiome research is translated to a product that consumers can benefit from," said...

SEREMI de Salud Grants Registration to Chile's First Finished Product Featuring Setria® Glutathione

de Salud. The supplement, developed by Nutrapharm, marks the first time a finished product containing Setria has received formal health authority approval in Chile — a significant milestone for the ingredient and for Chile's rapidly growing dietary...

Roquette Highlights Scalable Innovations in Drug Delivery

how its deep scientific expertise and technical capabilities enable pharmaceutical companies to turn promising formulations into scalable commercial realities. “As the pharmaceutical industry accelerates innovation, from GLP-1 therapies to complex...

X-Therma Launched XT-NoVo® and TimeSeal® Platform to Advance On-Demand Regenerative Medicine Beyond Cold Chain Constraints

biotechnology company focused on revolutionizing regenerative medicine through its innovative biopreservation platform, announced the commercial launch of its XT-NoVo® and TimeSeal® platform. This advanced end-to-end solution delivers ice-free,...

IMAAVY® (nipocalimab-aahu) demonstrated rapid onset and durable hemoglobin response in a pivotal Phase 2/3 study of warm autoimmune hemolytic anemia (wAIHA), a disease with no FDA-approved therapies

healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity. For more information please visit, https://www.jnj.com/

BEACON Real-World Study Shows Positive Top-Line Results for ZUNVEYL® in Alzheimer’s Disease, Reports Alpha Cognition

and Long-Term Care Practitioner. “The provider-reported observations from BEACON provide descriptive real-world information regarding treatment experiences among long-term care patients receiving ZUNVEYL. While the study was not designed to...

TrueMed Selected by a Global Top-10 Pharmaceutical Company to Protect Three High-Volume Drug Brands Against Counterfeit Threats

with one of the world's ten largest pharmaceutical companies. The agreement brings TrueMed's AI-powered authentication platform to three of the partner's established antibiotic and anti-infective products, medicines already in wide circulation that...

Growing Demand for Digital Pharmacy Underscores TelyRx Surpassing 1 Million Prescriptions

TelyRx Holdings Inc. a technology-enabled healthcare and online pharmacy platform focused on expanding access to FDA-approved medications across the United States, today announced it has surpassed one million prescriptions filled nationwide since...

Beauty Crush Skincare Introduces a New Standard in Regenerative Biotech Skincare

Beauty Crush Skincare, the latest venture from innovative beauty leader Karen Behnke, debuts and once again introduces formulas that challenge the industry with a new era of regenerative biotechnology-driven skincare. The collection combines a...

Brain Navi’s KrystoLens Receives TFDA Certification and Is Set to Enter the Taiwan Market

confirms that the product complies with Taiwan's medical device regulatory requirements and paves the way for its formal introduction into the local healthcare market. Developed with clinical needs in mind, KrystoLens is designed to help reduce the...